Document is current
Any future updates will be listed below
-
Authors
Goto, Tatsunori https://orcid.org/0000-0002-0314-9498
Numata, Hiroki
Katsuoka, Yuna
Uoshima, Nobuhiko
Hara, Satoru
Ando, Jun
Ota, Shuichi
Yoshimoto, Goichi
Matsuoka, Akihito
Hashiba, Hideyuki
Morita, Tetsuo
Tsutsui, Atsuko
Imanaka, Ryota
-
Funding
Funding for this research was provided by:
AbbVie GK
- License Information
-
More Information
Article History
Received: 30 August 2024
Accepted: 20 February 2025
First Online: 7 March 2025
Declarations
:
: Tatsunori Goto, Hiroki Numata, Yuna Katsuoka, Nobuhiko Uoshima, Satoru Hara, Jun Ando, and Ryota Imanaka received research funding from AbbVie. Jun Ando and Goichi Yoshimoto received lecture fees from AbbVie. Shuichi Ota received lecture fees from AbbVie, AstraZeneca, Sanofi, and Novartis. Akihito Matsuoka has no conflicts to declare. Hideyuki Hashiba is an employee of AbbVie GK. Tetsuo Morita and Atsuko Tsutsui are employees of AbbVie GK and shareholders of AbbVie Inc.
: The VENUS study was conducted in accordance with the principles of Good Epidemiology Practices, applicable regulations and guidelines, the Helsinki Declaration, and the “Ethical Guidelines for Medical and Health Research Involving Human Subjects” implemented by the Ministry of Health, Labour and Welfare, Japan. Before study initiation, ethics approval was obtained from the Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan (approval number 2022-425).
